. 2020 Sep 24;56(3):157–165. doi: 10.4068/cmj.2020.56.3.157
© Chonnam Medical Journal, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
TABLE 1. Concerns about antipsychotic polypharmacy.
